- Home
- DCTH vs WDI Comparison
DCTH vs WDI Comparison
Compare DCTH & WDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- WDI
- Stock Information
- Founded
- DCTH 1988
- WDI 2021
- Country
- DCTH United States
- WDI United States
- Employees
- DCTH N/A
- WDI N/A
- Industry
- DCTH Medical/Dental Instruments
- WDI Trusts Except Educational Religious and Charitable
- Sector
- DCTH Health Care
- WDI Finance
- Exchange
- DCTH Nasdaq
- WDI Nasdaq
- Market Cap
- DCTH 630.4M
- WDI 753.0M
- IPO Year
- DCTH N/A
- WDI N/A
- Fundamental
- Price
- DCTH $16.30
- WDI $14.70
- Analyst Decision
- DCTH Strong Buy
- WDI
- Analyst Count
- DCTH 4
- WDI 0
- Target Price
- DCTH $24.00
- WDI N/A
- AVG Volume (30 Days)
- DCTH 610.5K
- WDI 192.6K
- Earning Date
- DCTH 05-08-2025
- WDI 01-01-0001
- Dividend Yield
- DCTH N/A
- WDI 11.80%
- EPS Growth
- DCTH N/A
- WDI N/A
- EPS
- DCTH N/A
- WDI 1.12
- Revenue
- DCTH $53,850,000.00
- WDI N/A
- Revenue This Year
- DCTH $141.47
- WDI N/A
- Revenue Next Year
- DCTH $49.31
- WDI N/A
- P/E Ratio
- DCTH N/A
- WDI $12.82
- Revenue Growth
- DCTH 1068.87
- WDI N/A
- 52 Week Low
- DCTH $6.33
- WDI $12.16
- 52 Week High
- DCTH $18.23
- WDI $14.69
- Technical
- Relative Strength Index (RSI)
- DCTH 58.68
- WDI 67.47
- Support Level
- DCTH $15.73
- WDI $14.50
- Resistance Level
- DCTH $17.29
- WDI $14.68
- Average True Range (ATR)
- DCTH 0.96
- WDI 0.16
- MACD
- DCTH -0.08
- WDI 0.01
- Stochastic Oscillator
- DCTH 50.58
- WDI 82.69
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
About WDI Western Asset Diversified Income Fund of Beneficial Interest
Western Asset Diversified Income Fund is a newly-organized, diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income.